BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2000
View Archived Issues
AeroGen to develop inhaler device for cystic fibrosis agent
Read More
Oxigene and Techniclone join forces to develop new-generation anticancer agents
Read More
OvaRex shows evidence of cellular immune response
Read More
Amarillo Biosciences reports results of phase II trial of IFN-alpha in fibromyalgia
Read More
Pfizer and Warner-Lambert schedule shareholder meetings to consider merger
Read More
FDA approval sought for Imitrex in the treatment of adolescent migraine
Read More
CE Mark granted for the Prosorba Column as rheumatoid arthritis Rx
Read More
Ciba Vision seeks approval of Rescula on two continents for treatment of glaucoma
Read More
Santen presents new chymase inhibitors especially for cardiovascular disorders
Read More
Novel dihydropyrimidines from Merck are potent and selective alpha1A-adrenoceptor antagonists
Read More
New inhibitors of NOS, particularly iNOS, in early development at AstraZeneca
Read More
Tricyclic 5alpha-reductase inhibitors designed at Merck & Co.
Read More
Italian research institute searches for new enzyme-inhibitory antiviral agents
Read More
New compounds for cancer developed at Abbott
Read More
Back in the limelight: vasopeptidase inhibitor omapatrilat featured at ACC
Read More
Integrin receptor blockade assessed at DuPont for angiogenesis-mediated disorders
Read More
Bioglan Pharma and Sakai to jointly develop ES-Gel aciclovir formulation
Read More
Exochelin has potential in restenosis, according to data presented to the ACC
Read More
Neuromuscular blocking conopeptides evaluated in rat model; results reported at IARS congress
Read More
Synapse Technologies to work with VA on diagnostic for AD
Read More
Merger of three companies to create Genzyme Biosurgery
Read More
Alizyme receives notice of allowance, manufacturing license for mucositis product
Read More
Bivalirudin versus heparin during PTCA: six-month outcomes favor bivalirudin in post-MI patients
Read More
New treatment options for restenosis a hot topic at ACC
Read More
Detrusitol available in Spain for hyperactive bladder
Read More
Phase II study compares Vasoflux and heparin in AMI patients
Read More
